Mylan N.V. (MYL) EPS Estimated At $1.04 on May, 9

April 17, 2018 - By Russell Jones

Mylan N.V. (NASDAQ:MYL) Corporate Logo
Big Money Sentiment increased to 3 in Q4 2017. It has change of 2.67, from 2017Q3’s 0.33. The ratio improved due to Mylan N.V. positioning: 0 sold and 1 reduced. 3 funds bought holdings and 0 increased holdings. Investors holded 155,019 in 2017Q3 but now own 292,846 shares or 88.91% more.
Van Hulzen Asset Limited Liability Company invested in 1.55% or 120,545 shs. Vantage Invest Advsr Lc accumulated 337 shs. Gulf Bank & Trust (Uk) Limited holds 139,930 shs. Mirae Asset Ltd, a Korea-based fund reported 17,231 shs.

Mylan N.V. (NASDAQ:MYL)’s earnings report is awaited On May, 9., RTT reports. Analysts forecast $1.04 EPS. That’s $0.11 up or 11.83 % from 2017’s earnings of $0.93. MYL’s profit could hit $535.38 million if the current EPS of $1.04 is accurate. Last quarter $1.43 EPS was reported. Analysts forecasts -27.27 % negative EPS growth this quarter. MYL reached $40.72 on during the last trading session after $0.1 change.Currently Mylan N.V. is downtrending after 5.23% change in last April 17, 2017. MYL has 1.78 million shares volume. MYL underperformed the S&P 500 by 16.78%.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

In total 14 analysts cover Mylan Inc (NASDAQ:MYL). “Buy” rating has 11, “Sell” are 0, while 3 are “Hold”. 79% are bullish. 24 are the (NASDAQ:MYL)’s analyst reports since October 20, 2017 according to StockzIntelligence Inc. On Tuesday, March 6 the company was upgraded by Morgan Stanley. In Thursday, January 18 report Wells Fargo maintained it with “Hold” rating and $43.0 target. The company rating was maintained by BMO Capital Markets on Monday, October 30. On Thursday, January 4 Citigroup maintained Mylan N.V. (NASDAQ:MYL) with “Buy” rating. On Thursday, March 1 the stock has “Buy” rating by UBS. On Thursday, April 12 the company was maintained by Mizuho. On Tuesday, April 3 the company was maintained by RBC Capital Markets. On Thursday, December 21 the stock of Mylan N.V. (NASDAQ:MYL) earned “Hold” rating by Cantor Fitzgerald. The company rating was maintained by Mizuho on Thursday, March 15. On Thursday, January 18 the rating was maintained by Mizuho with “Buy”.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The firm is valued at $20.96 billion. The firm operates through three divisions: North America, Europe, and Rest of World.The P/E ratio is 31.32. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.